Salesforce CRM is scheduled to release third-quarter fiscal 2022 results on Nov 30.
For the fiscal third quarter, the company projects total revenues between $6.78 billion and $6.79 billion. Also, non-GAAP earnings are expected between 91 cents and 92 cents per share.
The Zacks Consensus Estimate for revenues is pegged at $6.79 billion, indicating an increase of 25.3% from the year-ago quarter’s reported figure.
The consensus mark for earnings has remained unrevised at 92 cents per share for the past 60 days. The bottom line is expected to decrease 47.1% year over year.
Salesforce’s earnings beat the Zacks Consensus Estimate in all the trailing four quarters, the average surprise being 68.5%.
Let’s see how things have shaped up before this announcement.
Factors to Consider
Salesforce’s third-quarter performance is likely to have benefited from the robust demand environment as customers have been undergoing a major digital transformation. The customer relationship management software provider’s focus on introducing more aligned products per customer needs is expected to have boosted its top line in the quarter under review.
Salesforce’s ability to offer integrated solutions for customers’ business problems is likely to have been a key growth driver. The firm’s products like Trailhead and myTrailhead are helping companies through their transformation processes along with an increasing business scale with modern technology.
Growth across its four major cloud service offerings, Sales Cloud, Service Cloud, Platform and other plus Marketing & Commerce Cloud, is anticipated to have boosted Salesforce’s subscription and supported its revenue stream, a major catalyst.
The company’s quarterly performance is also likely to have gained from its firm focus on building and expanding relationships with the leading brands across industries and geographies. Also, significant growth opportunities in the public sector are expected to have been a tailwind during the quarter under review.
The acquisitions of the likes of Slack, Mobify and Vlocity are anticipated to have aided the company’s top-line growth during the to-be-reported quarter.
However, a decline in software spending by small & medium businesses amid the macroeconomic uncertainty due to the COVID-19 pandemic might have affected Salesforce’s fiscal third-quarter performance.
Further, stiff competition from Oracle and Microsoft is a concern along with the forex headwinds. Also, increasing investments in International expansions and data centers might have eroded the company’s profitability during the to-be-reported quarter.
What Our Model Says
Our proven model does not conclusively predict an earnings beat for Salesforce this season. The combination of a positive Earnings ESP and Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. However, that’s not the case here. You can uncover the best stocks to buy or sell, before they’re reported, with our Earnings ESP Filter.
Though Salesforce currently carries a Zacks Rank #2, it has an Earnings ESP of -0.40%.
You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks With Favorable Combinations
Per our model, PVH Corporation PVH, AutoZone AZO and Lululemon Athletica LULU have the right combination of elements to post an earnings beat in their upcoming releases.
PVH Corporation is slated to report third-quarter fiscal 2022 results on Dec 1. Shares of PVH Corp. sport a Zacks Rank #1 and have an Earnings ESP of +1.61% at present. PVH’s earnings beat the Zacks Consensus Estimate thrice in the preceding four quarters while missed the same on one occasion, the average surprise being 177.5%.
The Zacks Consensus Estimate for quarterly earnings is pegged at $2.07 per share, suggesting a year-over-year improvement of 56.8%. PVH’s quarterly revenues are estimated to increase 13.4% year over year to $2.40 billion.
AutoZone carries a Zacks Rank #2 and has an Earnings ESP of +2.68%. The company is scheduled to report first-quarter fiscal 2022 results on Dec 7. AutoZone’s earnings have surpassed the Zacks Consensus Estimate in all the trailing four quarters, the average surprise being 18.6%.
The Zacks Consensus Estimate for AZO’s first-quarter earnings is pegged at $20.65 per share, representing a year-over-year decline of 11%. The consensus mark for revenues is pinned at $3.33 billion, reflecting a year-over-year decrease of 5.6%.
Lululemon currently carries a Zacks Rank #2 and has an Earnings ESP of +1.44%. Lululemon is expected to report its third-quarter fiscal 2022 results on Dec 9. LULU’s earnings beat the Zacks Consensus Estimate in all the trailing four quarters, the average surprise being 25.2%.
The Zacks Consensus Estimate for Lululemon’s third-quarter earnings is pinned at $1.39 per share, reflecting year-over-year growth of 19.8%. LULU is estimated to report revenues of $1.43 billion, which suggests an increase of 28.1% from the year-ago quarter.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
salesforce.com, inc. (CRM): Free Stock Analysis Report
AutoZone, Inc. (AZO): Free Stock Analysis Report
lululemon athletica inc. (LULU): Free Stock Analysis Report
PVH Corp. (PVH): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Before you consider RM, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RM wasn't on the list.
While RM currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here